RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Neuro, They show both a single and a multi-dose SA trial (slide 21). Varney gave a Q2 start / Q4 finish timeline for the multi-dose, but as you said, there isn't money available for it, so it's somewhat moot at this point I guess.

They also list the ADHD trial (4 week study, to start Q2, with enrollment complete in Q4), plus an RD study using IV CX-717, as clinical goals for 2009, though also depending on funding.

BTW, do you remember if he said how many subjects would be in the SA trial? Thanks.